The U.S. Chamber of Commerce has filed a lawsuit against the Biden administration over the Medicare price negotiation provisions in the Inflation Reduction Act. Merck also filed a lawsuit earlier this week, making the Chamber of Commerce the second organization to challenge the measure. In a statement, the Chamber of Commerce argued that government price controls harm patients, limit access to medicine, and stifle American innovation. It also alleged that the Medicare Drug Price Negotiation Program established by the IRA violates the principles of separation of powers within the federal government by consolidating “unfettered and unchecked power” to the Department of Health and Human Services (HHS). In addition, the Chamber of Commerce echoed the argument that drug price controls would impede medical innovation. The organization has asked the court to block HHS from implementing the IRA’s drug price negotiation program entirely and to declare it unconstitutional. A spokesperson for HHS maintained that the department will vigorously defend the President’s drug price negotiation law.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
